Table of Contents Table of Contents
Previous Page  60 / 60
Information
Show Menu
Previous Page 60 / 60
Page Background NCCN.org/patients – For Patients

|

NCCN.org – For Clinicians

NCCN Foundation

®

gratefully acknowledges our industry supporter, Pharmacyclics, LLC., for their support in making available these

NCCN Guidelines for Patients

®

. NCCN independently develops and distributes the NCCN Guidelines for Patients. Our industry

supporters do not participate in the development of the NCCN Guidelines for Patients and are not responsible for the content and

recommendations contained therein.

PAT-N-0962-0117

Waldenström’s

Macroglobulinemia

/

Lymphoplasmacytic Lymphoma

Version 1.2017

275 Commerce Drive

Suite 300

Fort Washington, PA 19034

215.690.0300

NCCN

GUIDELINES

FOR PATIENTS

®